Fischbach W, Mössner J
Dis Colon Rectum. 1987 Aug;30(8):595-9. doi: 10.1007/BF02554805.
Based on the adenoma-carcinoma sequence the authors studied whether determination of serum carcinoembryonic antigen (CEA) provided any conclusions concerning malignant transformation of a colorectal adenoma. In 32 patients with single or multiple adenomas, serum CEA did not differ from 119 healthy individuals. In 43 percent, a decrease of CEA could be observed after polypectomy, while it increased in 22 percent or remained unchanged in 35 percent. No correlation was found between adenoma volume and serum CEA. There was a tendency toward a higher serum CEA level in patients with villous adenoma as compared with those with tubular structure. CEA concentrations were independent from the degree of cellular atypia, but polypectomy was followed by a decrease of serum CEA in villous adenoma or of moderate cellular atypia, reflecting a possible influence on production or shedding of CEA by these subtypes of adenoma. The results indicate, therefore, that serum CEA is not able to recognize the malignant potential of colorectal adenoma.
基于腺瘤-癌序列,作者研究了血清癌胚抗原(CEA)的测定是否能为结直肠腺瘤的恶变提供任何结论。在32例患有单个或多个腺瘤的患者中,血清CEA与119名健康个体没有差异。43%的患者在息肉切除术后可观察到CEA下降,而22%的患者CEA升高,35%的患者CEA保持不变。腺瘤体积与血清CEA之间未发现相关性。与具有管状结构的患者相比,绒毛状腺瘤患者的血清CEA水平有升高的趋势。CEA浓度与细胞异型程度无关,但绒毛状腺瘤或中度细胞异型患者在息肉切除术后血清CEA下降,这反映了这些腺瘤亚型可能对CEA的产生或释放有影响。因此,结果表明血清CEA无法识别结直肠腺瘤的恶性潜能。